A-252 Prognosis about survival in primary cutaneous B cell lymphoma: a monocentric study of clinical characteristics of 98 patients.

Autor: Cankaya, R. (AUTHOR), Kleiner, P.L. (AUTHOR), Hilke, F.J. (AUTHOR), Moritz, R. (AUTHOR), Eigentler, T. (AUTHOR), Schlaak, M. (AUTHOR), Dobos, G. (AUTHOR)

Publikováno v: European Journal of Cancer. 2024 Supplement 2, Vol. 211, pN.PAG-N.PAG. 1p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ther-PO-23 - Skin directed therapy superior to systemic treatment in primary cutaneous B-cell lymphoma? A study from the Charité cutaneous lymphoma registry on time to next treatment.

Autor: Cankaya, R (AUTHOR), Schulz, S (AUTHOR), Moritz, R (AUTHOR), Walter, F (AUTHOR), Schlaak, M (AUTHOR), Eigentler, T (AUTHOR), Dobos, G (AUTHOR)

Publikováno v: European Journal of Cancer. 2022 Supplement 1, Vol. 173, pS51-S51. 1p.

A-106 Use of pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicentre retrospective data analysis with 70 patients.

Autor: Hansen, I. (AUTHOR), Geidel, G. (AUTHOR), Abeck, F. (AUTHOR), Kött, J. (AUTHOR), Cankaya, R. (AUTHOR), Dobos, G. (AUTHOR), Mitteldorf, C. (AUTHOR), Nicolay, J.P. (AUTHOR), Albrecht, J.D. (AUTHOR), Menzer, C. (AUTHOR), Livingstone, E. (AUTHOR), Mengoni, M. (AUTHOR), Braun, A.D. (AUTHOR), Wobser, M. (AUTHOR), Klemke, C.-D. (AUTHOR), Tratzmiller, S. (AUTHOR), Assaf, C. (AUTHOR), Terheyden, P. (AUTHOR), Klespe, K.-C. (AUTHOR), Schneider, S.W. (AUTHOR)

Publikováno v: European Journal of Cancer. 2024 Supplement 2, Vol. 211, pN.PAG-N.PAG. 1p.